ECOG- Frequently Asked Questions about the E4402 ECOG clinical trial
Using Rituximab for patients with Non-Hodgkin's Lymphoma
Follow the link below to view the handout answering frequently asked
questions about the E4402 ECOG clinical trial for patients with
Non-Hodgkin's Lymphoma. This is a "Randomized Phase III Trial Comparing Two Different Rituximab Dosing Regimens for Patients with Low Tumor Burden Indolent non-Hodgkin's Lymphoma".
The document is in Adobe Acrobat format. If you do not already
have Adobe Acrobat Reader running on your computer you can
download this software free of charge from the Adobe web site.
Next topic
How to contact ECOG
All contents copyright © 2001 Eastern Cooperative Oncology Group.
All rights reserved.
Revised: February 28, 2005
